Magrolimab plus Azacitidine Versus Azacitidine plus Placebo in Untreated Higher Risk Myelodysplastic Syndrome: The Phase 3, Randomized, ENHANCE Study

Garcia-Manero G., Daver N., Xu J., Chao M., Chung T., Tan A., Wang Y., Wei A., Vyas P., Sallman D.

Type

Conference paper

Publication Date

10/2021

Volume

96

Pages

S3 - S3

Permalink